Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | IMP (inosine 5'-monophosphate) dehydrogenase 2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | 3-ketoacyl-ACP reductase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0617 |
Mycobacterium tuberculosis | Probable dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0617 |
Mycobacterium ulcerans | oxidoreductase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | 3-oxoacyl-ACP reductase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium leprae | POSSIBLE OXIDOREDUCTASE | 0.0525 | 0.0623 | 0.0623 |
Leishmania major | pteridine reductase 1 | 0.0525 | 0.0623 | 1 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0617 |
Mycobacterium ulcerans | 3-alpha-hydroxysteroid dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0525 | 0.0623 | 0.0617 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0623 |
Toxoplasma gondii | 2,4-dienoyl CoA reductase 2, peroxisomal family protein | 0.0525 | 0.0623 | 0.0562 |
Mycobacterium leprae | Probable inosine-5'-monophosphate dehydrogenase GuaB3 (IMP dehydrogenase 2) (inosinic acid dehydrogenase) (inosinate dehydrogena | 0.005 | 0.0006 | 0.0006 |
Leishmania major | dehydrogenase/oxidoreductase-like protein | 0.0525 | 0.0623 | 1 |
Toxoplasma gondii | 3-ketoacyl-(acyl-carrier-protein) reductase | 0.0525 | 0.0623 | 0.0562 |
Leishmania major | dehydrogenase/oxidoreductase-like protein | 0.0525 | 0.0623 | 1 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Leishmania major | 3-oxoacyl-ACP reductase, putative | 0.0525 | 0.0623 | 1 |
Mycobacterium ulcerans | 3-ketoacyl-ACP reductase | 0.0525 | 0.0623 | 0.0623 |
Wolbachia endosymbiont of Brugia malayi | Short-chain alcohol dehydrogenase family enzyme | 0.0525 | 0.0623 | 0.0562 |
Mycobacterium ulcerans | 3-oxoacyl-ACP reductase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0525 | 0.0623 | 0.0617 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0623 |
Trypanosoma brucei | pteridine reductase 1 | 0.0525 | 0.0623 | 1 |
Mycobacterium tuberculosis | Probable 3-oxoacyl-[acyl-carrier protein] reductase FabG2 (3-ketoacyl-acyl carrier protein reductase) | 0.0525 | 0.0623 | 0.0617 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0525 | 0.0623 | 1 |
Toxoplasma gondii | enoyl-acyl carrier reductase ENR | 0.7756 | 1 | 1 |
Echinococcus granulosus | 3 oxoacyl acyl carrier protein reductase | 0.0525 | 0.0623 | 1 |
Mycobacterium ulcerans | enoyl-(acyl carrier protein) reductase | 0.7756 | 1 | 1 |
Mycobacterium ulcerans | inosine 5-monophosphate dehydrogenase | 0.0089 | 0.0057 | 0.0057 |
Mycobacterium ulcerans | 20-beta-hydroxysteroid dehydrogenase FabG3 | 0.0525 | 0.0623 | 0.0623 |
Trypanosoma brucei | oxidoreductase-like protein | 0.0525 | 0.0623 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0623 |
Trichomonas vaginalis | hypothetical protein | 0.7756 | 1 | 0.5 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium tuberculosis | Possible 20-beta-hydroxysteroid dehydrogenase FabG3 (cortisone reductase) ((R)-20-hydroxysteroid dehydrogenase) | 0.0525 | 0.0623 | 0.0617 |
Onchocerca volvulus | 0.0525 | 0.0623 | 0.5 | |
Onchocerca volvulus | 0.0525 | 0.0623 | 0.5 | |
Mycobacterium ulcerans | 3-ketoacyl-ACP reductase | 0.0525 | 0.0623 | 0.0623 |
Loa Loa (eye worm) | retinol dehydrogenase 12 | 0.0525 | 0.0623 | 1 |
Schistosoma mansoni | dihydropteridine reductase | 0.0525 | 0.0623 | 1 |
Plasmodium falciparum | 3-oxoacyl-[acyl-carrier-protein] reductase | 0.0525 | 0.0623 | 0.0569 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.0525 | 0.0623 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Plasmodium falciparum | enoyl-acyl carrier reductase | 0.7756 | 1 | 1 |
Trypanosoma brucei | beta-ketoacyl-ACP reductase | 0.0525 | 0.0623 | 1 |
Mycobacterium leprae | Probable inosine-5'-monophosphate dehydrogenase GuaB2 (IMP dehydrogenase) (IMPDH) (IMPD) | 0.0095 | 0.0065 | 0.0065 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0623 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.0525 | 0.0623 | 1 |
Mycobacterium ulcerans | 3-ketoacyl-ACP reductase | 0.0525 | 0.0623 | 0.0623 |
Loa Loa (eye worm) | oxidoreductase | 0.0525 | 0.0623 | 1 |
Entamoeba histolytica | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0525 | 0.0623 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0525 | 0.0623 | 1 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.0525 | 0.0623 | 1 |
Plasmodium vivax | 3-oxoacyl-[acyl-carrier-protein] reductase, putative | 0.0525 | 0.0623 | 0.0569 |
Mycobacterium tuberculosis | Probable inosine-5'-monophosphate dehydrogenase GuaB2 (imp dehydrogenase) (inosinic acid dehydrogenase) (inosinate dehydrogenase | 0.0095 | 0.0065 | 0.0058 |
Schistosoma mansoni | 3-oxoacyl-[ACP] reductase | 0.0525 | 0.0623 | 1 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | 3-ketoacyl-ACP reductase | 0.0525 | 0.0623 | 0.0623 |
Wolbachia endosymbiont of Brugia malayi | enoyl-ACP reductase | 0.7756 | 1 | 1 |
Mycobacterium tuberculosis | NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) | 0.7756 | 1 | 1 |
Mycobacterium leprae | NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) | 0.7756 | 1 | 1 |
Plasmodium vivax | enoyl-acyl carrier protein reductase | 0.7756 | 1 | 1 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0617 |
Mycobacterium leprae | 3-OXOACYL-[ACYL-CARRIER PROTEIN] REDUCTASE FABG1 (3-KETOACYL-ACYL CARRIER PROTEIN REDUCTASE) (MYCOLIC ACID BIOSYNTHESIS A PROTEI | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0623 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0525 | 0.0623 | 0.0623 |
Toxoplasma gondii | short chain dehydrogenase family protein, putative | 0.0525 | 0.0623 | 0.0562 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.0525 | 0.0623 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0525 | 0.0623 | 0.0617 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.0525 | 0.0623 | 1 |
Leishmania major | oxidoreductase-like protein | 0.0525 | 0.0623 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0525 | 0.0623 | 0.0623 |
Echinococcus multilocularis | 3 oxoacyl acyl carrier protein reductase | 0.0525 | 0.0623 | 1 |
Mycobacterium ulcerans | inosine 5'-monophosphate dehydrogenase | 0.0095 | 0.0065 | 0.0065 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.